Medical News
POLAR Trial Offers New Hope for Some Patients With Metastatic Pancreatic Cancer
Early findings from the Phase 2 POLAR trial suggest that combining pembrolizumab and olaparib may benefit selected patients with metastatic pancrea...
PICCOS Clinical Trial Explores Innovative Treatment for Peritoneal Cancer
The PICCOS clinical trial is exploring an innovative chemotherapy approach called PIPAC for people with peritoneal cancer. Researchers hope this ta...
Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment
Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...
Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention
A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...
A Turning Point Before Surgery: CASSANDRA Redefines Neoadjuvant Therapy in Pancreatic Cancer
The CASSANDRA phase III trial shows that the PAXG regimen significantly improves outcomes over mFOLFIRINOX in resectable pancreatic cancer. This pa...
Europe Approves First-line Immunotherapy for Advanced Anal Cancer
New progress for advanced anal cancer in Europe. The European Commission has approved retifanlimab with chemotherapy as a first-line treatment, hel...
BATTMAN Trial Targets Breakthrough in Hard-to-Treat Colorectal Cancer
A new Phase III trial, BATTMAN, explores combination immunotherapy for MSS metastatic colorectal cancer, a group with limited options. By targeting...
Breakthroughs, Reality Checks, and New Directions in HBP Cancer Care
The annual American Society of Clinical Oncology – Gastrointestinal (ASCO-GI) meeting highlighted a major shift in treating Hepato-Bilio-Panc...
Expanding the Biomarker Landscape on Gastric Cancer
New research presented at the 2026 ASCO GI meeting shows that understanding the biology of gastric and gastroesophageal cancers is driving more per...
Progress in Pancreatic Cancer: Highlights from ESMO 2025
New data from ESMO 2025 bring fresh hope in pancreatic cancer treatment, featuring advances in KRAS G12D-targeted therapy (GFH375), antibody–drug...